Octreotide LAR in the Induction of Immunologic Response in NENs Patients
Condition: Neuroendocrine Tumors Intervention: Drug: Octreotide Acetate Sponsor: National Cancer Institute, Naples Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials